Constantin A Dasanu

46PUBLICATIONS
25CO-AUTHORS
Molecular medicineCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|May 26, 2026
Updates in the pharmacologic management of various Castleman disease subtypes: A comprehensive review.

|Mar 17, 2026
Primary central nervous system lymphoma: Evolving treatment strategies to achieve improved long-term disease control.

Moza Hamoud, Victor M Samperio, Ion Codreanu

|Oct 01, 2025
An update on the pharmacotherapy of penile cancer.

Victor M Samperio, Ifeoma Ike, Moza Hamoud

|Jul 08, 2025
Mosunetuzumab-associated fatal HHV-6 encephalitis in a patient with follicular lymphoma.

Victor M Samperio, Moza Hamoud, Constantin A Dasanu

|May 13, 2025
Complete color vision loss in a patient with metastatic melanoma of the skin treated with nivolumab-relatlimab.

Ruba Alchaikh Hassan, Anderson Vu, Henry Tsai

|Nov 25, 2024
Temozolomide overcoming resistance to immune checkpoint inhibitors in relapsed/refractory metastatic melanoma? Insights from a single center series.

Constantin A Dasanu, Steven C Plaxe

Pageof 8

Frequent Collaborators

6 joint publications

Andrew S Iskandar

6 joint publications

Shahat Tuler

6 joint publications

Jaspreet Kaur

5 joint publications

Ruba Hassan